Douglas K Novins1, Calvin D Croy2, Laurie A Moore2, Traci Rieckmann3. 1. Centers for American Indian and Alaska Native Health, University of Colorado Anschutz Medical Campus, United States. Electronic address: douglas.novins@ucdenver.edu. 2. Centers for American Indian and Alaska Native Health, University of Colorado Anschutz Medical Campus, United States. 3. Department of Public Health and Preventive Medicine, Oregon Health and Sciences University, United States.
Abstract
BACKGROUND: Research and health surveillance activities continue to document the substantial disparities in the impacts of substance abuse on the health of American Indian and Alaska Native (AI/AN) people. While Evidence-Based Treatments (EBTs) hold substantial promise for improving treatment for AI/ANs with substance use problems (as they do for non-AI/ANs), anecdotal reports suggest that their use is limited. In this study, we examine the awareness of, attitudes toward, and use of EBTs in substance abuse treatment programs serving AI/AN communities. METHODS: Data are drawn from the first national survey of tribal substance abuse treatment programs. Clinicians or clinical administrators from 192 programs completed the survey. Participants were queried about their awareness of, attitudes toward, and use of 9 psychosocial and 3 medication EBTs. RESULTS: Cognitive Behavioral Therapy (82.2%), Motivational Interviewing (68.6%), and Relapse Prevention Therapy (66.8%) were the most commonly implemented psychosocial EBTs; medications for psychiatric comorbidity was the most commonly implemented medication treatment (43.2%). Greater EBT knowledge and use were associated with both program (e.g., funding) and staff (e.g., educational attainment) characteristics. Only two of the commonly implemented psychosocial EBTs (Motivational Interviewing and Relapse Prevention Therapy) were endorsed as culturally appropriate by a majority of programs that had implemented them (55.9% and 58.1%, respectively). CONCLUSIONS: EBT knowledge and use is higher in substance abuse treatment programs serving AI/AN communities than has been previously estimated. However, many users of these EBTs continue to have concerns about their cultural appropriateness, which likely limits their further dissemination.
BACKGROUND: Research and health surveillance activities continue to document the substantial disparities in the impacts of substance abuse on the health of American Indian and Alaska Native (AI/AN) people. While Evidence-Based Treatments (EBTs) hold substantial promise for improving treatment for AI/ANs with substance use problems (as they do for non-AI/ANs), anecdotal reports suggest that their use is limited. In this study, we examine the awareness of, attitudes toward, and use of EBTs in substance abuse treatment programs serving AI/AN communities. METHODS: Data are drawn from the first national survey of tribal substance abuse treatment programs. Clinicians or clinical administrators from 192 programs completed the survey. Participants were queried about their awareness of, attitudes toward, and use of 9 psychosocial and 3 medication EBTs. RESULTS: Cognitive Behavioral Therapy (82.2%), Motivational Interviewing (68.6%), and Relapse Prevention Therapy (66.8%) were the most commonly implemented psychosocial EBTs; medications for psychiatric comorbidity was the most commonly implemented medication treatment (43.2%). Greater EBT knowledge and use were associated with both program (e.g., funding) and staff (e.g., educational attainment) characteristics. Only two of the commonly implemented psychosocial EBTs (Motivational Interviewing and Relapse Prevention Therapy) were endorsed as culturally appropriate by a majority of programs that had implemented them (55.9% and 58.1%, respectively). CONCLUSIONS:EBT knowledge and use is higher in substance abuse treatment programs serving AI/AN communities than has been previously estimated. However, many users of these EBTs continue to have concerns about their cultural appropriateness, which likely limits their further dissemination.
Authors: Janette Beals; Douglas K Novins; Paul Spicer; Nancy R Whitesell; Christina M Mitchell; Spero M Manson Journal: Psychiatr Serv Date: 2006-04 Impact factor: 3.084
Authors: Andrea Acevedo; Lee Panas; Deborah Garnick; Dolores Acevedo-Garcia; Jennifer Miles; Grant Ritter; Kevin Campbell Journal: J Behav Health Serv Res Date: 2018-10 Impact factor: 1.505
Authors: Sarah E Zemore; Katherine J Karriker-Jaffe; Nina Mulia; William C Kerr; Cindy L Ehlers; Won Kim Cook; Priscilla Martinez; Camillia Lui; Thomas K Greenfield Journal: J Stud Alcohol Drugs Date: 2018-01 Impact factor: 2.582
Authors: Daniel Dickerson; Laurie A Moore; Traci Rieckmann; Calvin D Croy; Kamilla Venner; Jacquelene Moghaddam; Rebekah Gueco; Douglas K Novins Journal: J Behav Health Serv Res Date: 2018-01 Impact factor: 1.505
Authors: Emily G Hichborn; Sarah K Moore; Phoebe R Gauthier; Nico O Agosti; Kathleen D Bell; Jesse S Boggis; Chantal A Lambert-Harris; Elizabeth C Saunders; Avery M Turner; Bethany M McLeman; Lisa A Marsch Journal: JMIR Res Protoc Date: 2022-05-17
Authors: David A Gilder; Jennifer R Geisler; Juan A Luna; Daniel Calac; Peter M Monti; Nichea S Spillane; Juliet P Lee; Roland S Moore; Cindy L Ehlers Journal: J Subst Abuse Treat Date: 2017-09-09